Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that GlaxoSmithKline (GSK) hired Kevin Sin as senior vice president and head of worldwide business development for pharmaceuticals R&D. Currently, Sin is vice president and global head of oncology business development at Genentech.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!